Sixth Circuit keeps Kentucky opioid case against PBMs in federal court
The Sixth Circuit reversed an order returning Kentucky's opioid lawsuit against Express Scripts and OptumRx to state court. The ruling addressed jurisdiction, without deciding liability.
The U.S. Court of Appeals for the Sixth Circuit ruled on September 18, 2026, in Commonwealth of Kentucky ex rel. Russell Coleman v. Express Scripts, Inc., et al., No. 25-5866. It reversed a remand order in an opioid lawsuit against Express Scripts entities and OptumRx.
Kentucky alleged the PBMs exchanged preferred opioid formulary placement for manufacturer rebates and fees, violating state consumer-protection law and creating a public nuisance. It sought civil penalties, injunctive relief and abatement; the appellate ruling awarded no damages.
The companies invoked federal-officer removal under 28 U.S.C. § 1442(a)(1), citing their work administering federal prescription benefits. Kentucky argued its disclaimer of claims involving federally directed conduct required state-court proceedings.
The court allowed federal jurisdiction and returned the case for further proceedings in the Eastern District of Kentucky, No. 5:24-cv-00303. It found colorable federal defenses sufficient for removal, without deciding those defenses on their merits. The opinion records no admission of liability.
Cite this report
The Precedent. "Sixth Circuit keeps Kentucky opioid case against PBMs in federal court." September 25, 2026. https://theprecedent.org/article/sixth-circuit-keeps-kentucky-opioid-case-against-pbms-in-federal-court
